MIVI Neuroscience's R4Q Catheter for Ischemic Stroke Approved and Commercialized in Europe
July 2, 2018—MIVI Neuroscience, Inc. announced the expansion of its European commercialization network for the R4Q revascularization catheter for the treatment of ischemic stroke.
The R4Q system's suite of devices, which received European CE Mark approval in March, will be introduced with a focused launch through a network of experienced neurovascular distribution partners. Most recently, the company received a commitment from AngioNautix of Madrid, Spain, to be its partner in Spain, Portugal, and Cuba. MIVI is also partnered with Neurologic Europe Ltd. in the United Kingdom, and Med-Italia Biomedica, S.r.l. in Italy.
advertisement
Featured Video
Type B Aortic Dissection
Sponsored by Medtronic
Related Articles
Carotid Occlusion With Middle Cerebral Artery Thrombus
By Moderators: Adnan H. Siddiqui, MD, PhD; and Kunal Vakharia, MD;
Panel: Ansaar T. Rai, MD, MBA; and Aquilla S. Turk, DO
Top 5 Articles From June 2018
Global Roundtable: Real-World Experience With Drug-Coated Balloons in AV Access
Experts discuss the current use of DCBs in AV fistulas and review how upcoming trials may influence progress in this space.
With Andrew Holden, MBChB, FRANZCR, EBIR; Farah Gillan Irani, MBBS, FRCR, FAMS; Dimitrios Karnabatidis, MD, PhD, FCIRSE; Panagiotis M. Kitrou, MD, MSc, PhD, EBIR; Bien Soo Tan, MBBS, FRCR, FAMS; and Scott O. Trerotola, MD
Dialysis Access: Boldly Entering a New Era in Decision-Making
By Bart L. Dolmatch, MD, FSIR; and Saravanan Balamuthusamy, MD, FASN, FASDIN
Creating CLI Teams
The VIVA Physicians’ Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.
By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants
The SIR TCVO Reporting Standards: Why You Should Care
How the new reporting standards on thoracic central vein obstruction can be applied to clinical practice.
By Bart L. Dolmatch, MD, FSIR
Top 5 from CIToday's Current Issue
Transcatheter Chordal Repair for Degenerative Mitral Regurgitation
Current and future directions of therapeutic options for patients with degenerative MR.
By Andrea Colli, MD, PhD; Alessandro Fiocco, MD; Nicola Pradegan, MD; Matteo Nadali, MD; Laura Besola, MD; Eleonora Bizzotto, MD; and Gino Gerosa, MD
An Update on Transcatheter Tricuspid Valve Therapies
A review of the current state of transcatheter tricuspid valve therapies and where they are headed next.
By Antonio Mangieri, MD; Giorgios Tzanis, MD; and Azeem Latib, MD
Transcatheter Leaflet Repair for Functional MR
What will randomized trials mean for the future of mitral intervention?
By Ted Feldman, MD, FESC, FACC, MSCAI; Paul Sorajja, MD, FACC, FSCAI; Paul Grayburn, MD, FACC, FSCAI; and Francesco Maisano, MD
Clinical Data for Stenting High-Risk Patients Requiring Short DAPT
Discussing the clinical benefits of the COBRA PzF NanoCoated Coronary Stent (NCS).
With Gilles Montalescot, MD, PhD; Axel de Labriolle, MD, PhD; and Donald Cutlip, MD
State of the Art of Transcatheter Mitral Annuloplasty: Present and Future
An appraisal of current and upcoming devices for direct and indirect transcatheter annuloplasty procedures.
